Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors

DSpace Repository

Phase I study of VSV-GP (BI 1831169) as monotherapy or combined with ezabenlimab in advanced and refractory solid tumors

Author: Porosnicu, Mercedes; Quinson, Anne-Marie; Crossley, Kate; Luecke, Stephan; Lauer, Ulrich M.
Tübinger Autor(en):
Lauer, Ulrich Manfred
Published in: Future Oncology (2022), Bd. 18, H. 24, S. 2627-2638
Verlagsangabe: Future Medicine Ltd
Language: English
Full text: http://dx.doi.org/10.2217/fon-2022-0439
ISSN: 1479-6694
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)